Combination of targeted treatment drugs delays resistance in melanoma patients
Saturday, September 29, 2012 - 22:30
in Health & Medicine
Combined treatment with two drugs targeting different points in the same growth-factor pathway delayed the development of treatment resistance in patients with BRAF-positive metastatic malignant melanoma.